Almujtama Alraida Medical Co. vs Al Razi Medical Company
A head-to-head of Almujtama Alraida Medical Co. (9592) and Al Razi Medical Company (9572) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 9592 | 9572 |
|---|---|---|
| Market Cap | 213.75M SAR | 43.05M SAR |
| P/E (TTM) | 25.18 | 58.85 |
| Forward P/E | — | — |
| P/S | — | 0.58 |
| P/B | 1.44 | 2.06 |
| EV/EBITDA | — | 16.74 |
| Dividend Yield | 111.00% | — |
| Profit Margin | 1.85% | 1.10% |
| Gross Margin | 32.93% | 25.94% |
| Operating Margin | 2.36% | 2.65% |
| Revenue Growth (YoY) | — | +34.00% |
| FCF Yield | — | — |
| Debt / Equity | — | 11.78 |
| Current Ratio | 1.07 | 1.47 |
Which is better: Almujtama Alraida Medical Co. or Al Razi Medical Company?
- ✓Larger by market cap: Almujtama Alraida Medical Co.
- ✓Cheaper valuation (lower P/E): Almujtama Alraida Medical Co.
- ✓More profitable (net margin): Almujtama Alraida Medical Co.
Across 6 available metrics, Almujtama Alraida Medical Co. leads 4–2.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Almujtama Alraida Medical Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.